Cardiovascular effects of dihydrotestosterone in rats

Legal Medicine

Volumn 1, Issue 2, 1999, Pages 95-104

  Tsunoda, Kenji ^a   Yamaguchi, Yoshitsugu ^b   Taguchi, Tomoko ^a   Doge, Koichi ^a   Kato, Yoshiki ^a   Sato, Akira ^a   Sato, Keizo ^a  

^a SHOWA UNIVERSITY   (Japan)

^b Tokyo Medical Examiner's Office   (Japan)

Author keywords

5 dihydrotestosterone; Cardiovascular system; Obese rat; Right ventricular hypertrophy; Sudden death

Indexed keywords

EID: 10644257595     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1344-6223(99)80019-4     Document Type: Article

References (27)

1. Bachmann J, Ganten U, Stock G, Ganten D. Sexual dimorphism of cardiovascular function: The role of androgens. In: Ramwell P, Rubanyi G, Schillinger E, editors. Sex steroids and the cardiovascular system; In Schering foundation workshop 5. Berlin and Heidelberg: Springer-Verlag; 1992. pp.9-30.
2. Molteni A, Brownei AC, Skelton FR. Production of hypertensive vascular disease in the rat by methyltestosterone. Lab Invest 1969; 21: 129-37.
3. Moore LG, McMurtry IF, Reeves JT. Effects of sex hormones on cardiovascular and hematologic responses to chronic hypoxia in rats. Pro Soc Exptl Biol Med 1978; 158: 658-62.
4. Pesola MK. Reversibility of the haemodynamic effects of anabolic steroids in rats. Eur J Appl Physiol 1988; 58: 125-31.
5. Trifunovic B, Norton GR, Duffield MJ, Avraam P, Woodiwiss AJ. An androgenic steroid decreases left ventricular compliance in rats. Am J Physiol 1995: H1095-105.
6. Luke JL, Farb A, Virmani R, Barry Sample RH. Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: Pathological and toxicological findings, J Forensic Sci 1990; 35: 1441-47.
7. Melchert RB, Welder AA. Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc 1995;27:1252-62.
8. Tsunoda K, Watanabe T, Tokutome S. Concentrations of plasma testosterone in sudden manhood death syndrome. Jpn J Leg Med 1997; 51: 26-31.
9. Skelton FR. The production of hypertension, nephrosclerosis and cardiac lesions by methylandrostenediol treatment in the rat. Endocrinology 1953; 53: 492-505.
10. Fischer GM, Swain ML. Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am J Physiol 1977; 232: 617-21.
11. Ramo P. Anabolic steroids alter the haemodynamic responses of the canine left ventricle. Acta Physiol Scand 1987; 130: 209-17.
12. Lengsfeld M, Morano I, Ganten U, Ganten D, Ruegg JC. Gonadectomy and hormonal replacement changes systolic blood pressure and ventricular myosin isozyme pattern of spontaneously hypertensive rats. Circ Res 1988; 63: 1090-94.
13. Kinson GA, Layberry RA, Hebert B. Influences of anabolic androgens on cardiac growth and metabolism in the rat. Can J Physiol Pharmacol 1991; 69: 1698-704.
14. Shaper AG. Obesity and cardiovascular disease. Ciba Found Symp 1996; 25: 90-103.
15. Ishikawa S, Mochizuki S, Ozasa H, Saso F, Saito N, Inoue S, Abe M. Cardiac function and metabolism in experimental obese rats - Effect of ischemia and reperfusion. Igagu no ayumi 1982; 122: 793-95. (in Japanese)
16. Fulton RM, Hutchinson EC, Morgan Jones A. Ventricular weight in cardiac hypertrophy. Br Heart J 1952; 14: 413-20.
17. Hultgren HN, Marticorena E, Miller H. Right ventricular hypertrophy in animals at high altitude. J Appl Physiol 1963; 18: 913-18.
18. Krieg M, Smith K, Bartsch W. Demonstration of a specific androgen receptor in rat heart muscle: Relationship between binding, metabolism, and tissue levels of androgens. Endocrinology 1978; 103: 1686-94.
19. Koenig H, Goldstone A, Lu CY. Testosterone-mediated sexual dimorphism of the rodent heart. Circ Res 1982; 50: 782-87.
20. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 1998; 98: 256-61.
21. Urhausen A, Holpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids.Eur J Appl Physiol 1989; 58: 633-40.
22. Ganong WF. Cardiovascular regulatory mechanisms. In: Maruzen Asian edition. Review of medical physiology; Los Altos, California: Lang Medical Publications; 1983. pp. 477-87.
23. Strumpf IJ, Reynolds SF, Vash P, Tashkin DP. A possible relationship between testosterone central control of ventilation and the Pickwickian syndrome. Am Rev Respir Dis 1978; 117 (Suppl): 183.
24. Sandblom RE, Matsumoto AM, Schoene RB, Lee KA, Giblin EC, Pierson DJ, Bremner WJ. Obstructive sleep apnea syndrome induced by testosterone administration. N Engl J Med 1983; 308: 508-10.
25. Matsumoto AM, Sandblom RE, Schoene RB Lee KA, Giblin EG, Pierson DJ, Bremner WJ. Testosterone replacement in hypogonadal men: Effect of obstructive sleep apnea, respiratory drives, and sleep. Clin Endocrinol 1985; 22: 713-21.
26. White DP, Schneider BK, Santen RJ, McDermott M, Pickett CK, Zwillich CW, Weil JV. Influence of testosterone on ventilation and chemosensitivity in male subjects. J Appl Physiol 1985; 59: 1452-57.
27. 2 and pH in the case of sudden and unexpected death. Jpn J Legal Med 1973; 27: 248-54. (in Japanese with English abstract)